[HTML] springer.com

[HTML][HTML] Tapinarof cream 1%: first approval

SJ Keam - Drugs, 2022 - Springer
Abstract Tapinarof cream 1%(VTAMA®) is an aryl hydrocarbon receptor (AhR) agonist that is
being developed by Dermavant Sciences Inc.(a subsidiary of Roivant Sciences Inc.) as a …
被引用次数：51 相关文章

Tapinarof Cream 1%: First Approval.

SJ Keam - Drugs, 2022 - europepmc.org
Abstract Tapinarof cream 1%(VTAMA®) is an aryl hydrocarbon receptor (AhR) agonist that is
being developed by Dermavant Sciences Inc.(a subsidiary of Roivant Sciences Inc.) as a …

Tapinarof Cream 1%: First Approval

SJ Keam - Drugs, 2022 - pubmed.ncbi.nlm.nih.gov
Tapinarof cream 1%(VTAMA®) is an aryl hydrocarbon receptor (AhR) agonist that is being
developed by Dermavant Sciences Inc.(a subsidiary of Roivant Sciences Inc.) as a once …

Tapinarof Cream 1%: First Approval.

SJ Keam - Drugs, 2022 - search.ebscohost.com
Abstract Tapinarof cream 1%(VTAMA< sup>®</sup>) is an aryl hydrocarbon receptor (AhR)
agonist that is being developed by Dermavant Sciences Inc.(a subsidiary of Roivant …

Tapinarof Cream 1%: First Approval

SJ Keam - Drugs, 2022 - search.proquest.com
Abstract Tapinarof cream 1%(VTAMA®) is an aryl hydrocarbon receptor (AhR) agonist that is
being developed by Dermavant Sciences Inc.(a subsidiary of Roivant Sciences Inc.) as a …
[HTML] nih.gov

[HTML][HTML] Tapinarof Cream 1%: First Approval

SJ Keam - Drugs, 2022 - ncbi.nlm.nih.gov
Abstract Tapinarof cream 1%(VTAMA®) is an aryl hydrocarbon receptor (AhR) agonist that is
being developed by Dermavant Sciences Inc.(a subsidiary of Roivant Sciences Inc.) as a …

Tapinarof Cream 1%: First Approval.

SJ Keam - Drugs, 2022 - europepmc.org
Tapinarof cream 1%(VTAMA®) is an aryl hydrocarbon receptor (AhR) agonist that is being
developed by Dermavant Sciences Inc.(a subsidiary of Roivant Sciences Inc.) as a once …